Healthcare IT Today

AUGUST 9, 2022

The use of AI is revolutionizing the delivery of healthcare, but its use comes with significant ethical challenges that cannot be ignored, the most important of which involve bias and informed consent. . Another major ethical concern of AI use surrounds the principle of informed consent. Overall Recommendations .

Informed Consent 130

Informed Consent FDA Hospitals Compliance 130

Hall Render

SEPTEMBER 14, 2023

Food and Drug Administration (“FDA”) released draft guidance regarding the conduct of decentralized clinical trials (“DCTs”) for drugs, biological products and devices. This draft guidance expands on previous FDA recommendations released in the midst of the COVID-19 pandemic.

FDA 40

FDA Informed Consent COVID-19 Fraud 40

HIT Consultant

NOVEMBER 17, 2021

Recent statements by the FDA and EMA support this emphasis, calling out the need for education and training of all constituents in a clinical trial to reduce unwanted protocol deviations and improve overall quality in clinical trial operations. Improving Protocol Compliance.

COVID-19 97

COVID-19 Pharmaceutical Industry Informed Consent Compliance 97

Hall Render

OCTOBER 5, 2023

Food and Drug Administration (“FDA”) finalized “ Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors ” (“Final Guidance”), following the FDA’s earlier issuance of draft guidance on the subject in July 2014. On August 15, 2023, the U.S.

Informed Consent 40

Informed Consent FDA Compliance Regulatory Compliance 40

SQA

MAY 17, 2022

China Regulatory Roundup: Latest Guidelines for Medical Device and IVD Compliance, 17 March 2022. For Investigator Sites, the subject areas are Organizational Aspects, Informed Consent of Trial Participants, Review of Trial Participant Data, and Management of Investigational Medicinal Product(s).

FDA 75

FDA Compliance Informed Consent Hospitals 75

SQA

FEBRUARY 15, 2023

Of interest is a reference to the FDA’s draft document “Computer Software Assurance for Production and Quality System Software,” which was recently published on 13 September 2022. PCPC looks forward to working with the FDA and key stakeholders to implement this important legislation.

US Department of Health and Human Services 40

US Department of Health and Human Services FDA COVID-19 World Health 40

Healthcare IT Today

JUNE 13, 2024

Ownership and protection of data are paramount, with compliance issues such as HIPAA regulations adding complexity. Questions surrounding the sharing of proprietary information and the risk of algorithmic compromise or manipulation heighten ethical concerns. This creates the opportunity for bias related to location.

Governance 84

Governance HIPAA Hospitals Informed Consent 84